Genix Pharmaceuticals (TSE:GENX)
TSXV:GENX
Canadian Market

Genix Pharmaceuticals (GENX) Financial Statements

1 Followers

Genix Pharmaceuticals Financial Overview

Genix Pharmaceuticals's market cap is currently ―. The company's EPS TTM is C$-0.068; its P/E ratio is -1.16; Genix Pharmaceuticals is scheduled to report earnings on September 26, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Apr 24Jan 24Oct 23Jul 23Apr 23
Income Statement-
Total RevenueC$ 8.08KC$ 71.00-C$ 2.68KC$ 8.08K
Gross ProfitC$ 189.00C$ 58.00-C$ 2.25KC$ 189.00
EBITC$ -225.05KC$ -35.16KC$ -3.74MC$ -154.01KC$ -225.05K
EBITDAC$ -224.77KC$ -34.88KC$ -3.61MC$ -18.09KC$ -87.64K
Net Income Common StockholdersC$ -234.02KC$ -59.06KC$ -3.77MC$ -164.10KC$ -234.02K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 9.55KC$ 9.30KC$ 11.63KC$ 4.24KC$ 40.36K
Total AssetsC$ 247.37KC$ 246.70KC$ 223.46KC$ 3.84MC$ 4.02M
Total DebtC$ 1.24MC$ 1.15MC$ 511.52KC$ 988.74KC$ 969.52K
Net DebtC$ 1.23MC$ 1.14MC$ 499.89KC$ 984.50KC$ 929.16K
Total LiabilitiesC$ 1.53MC$ 1.44MC$ 1.36MC$ 1.27MC$ 1.29M
Stockholders EquityC$ -1.28MC$ -1.20MC$ -1.14MC$ 2.57MC$ 2.74M
Cash Flow-
Free Cash FlowC$ -58.50KC$ -42.56KC$ -60.55KC$ -52.83KC$ -55.82K
Operating Cash FlowC$ -58.50KC$ -42.56KC$ -60.55KC$ -52.83KC$ -55.82K
Investing Cash Flow-----
Financing Cash FlowC$ 58.75KC$ 40.23KC$ 67.95KC$ 16.71KC$ 54.90K
Currency in CAD

Genix Pharmaceuticals Earnings and Revenue History

Genix Pharmaceuticals Debt to Assets

Genix Pharmaceuticals Cash Flow

Genix Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis